Financial Year |
March 31 2023 |
Monetary Funds |
720,475,698.07 |
Held-for-trading Financial Assets |
203,410,397.54 |
Notes Receivable |
107,884,134.96 |
Accounts Receivable |
552,369,189.03 |
Advances to Suppliers |
17,199,849.78 |
Other Receivables |
5,022,973.75 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
315,087,440.92 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,519,282.98 |
Total Current Assets |
2,007,167,061.73 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
554,354,587.39 |
Under-construction Projects |
129,871,919.32 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
92,804,045.92 |
R&D expenses |
-- |
Goodwill |
44,571,557.44 |
Long-Term Deferred and Prepaid Expenses |
1,942,261.36 |
Deferred Income Tax Assets |
13,389,238.41 |
Other Non-Current Assets |
9,018,734.30 |
Sub-Total of Non-Current Assets |
878,850,010.56 |
Total Assets |
2,886,017,072.29 |
Short-Term Loans |
234,500,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
29,664,684.67 |
Accounts Payable |
213,330,557.44 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
15,649,918.86 |
Taxes Payable |
23,705,944.61 |
Interest Payable |
32,500.00 |
Dividend Payable |
-- |
Other payables |
12,850,531.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,207,298.32 |
Other Current Liabilities |
4,411,232.69 |
Sub-Total of Current Liabilities |
576,201,479.34 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
1,656,042.96 |
Deferred Income Tax Liabilities |
3,862,052.25 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
28,892,495.74 |
Total Liabilities |
605,093,975.08 |
Paid-In Capital(Or Share Stock) |
391,090,200.00 |
Capital Surplus |
826,119,538.70 |
Surplus Reserve |
104,037,381.31 |
LESS:Treasury Stock |
1,290,470.00 |
Undistributed Profits |
955,586,222.63 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,280,923,097.21 |
Owner's Equity(Stockholder's Equity) |
2,280,923,097.21 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,886,017,072.29 |